Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1976 Jul;34(1):7-13.
doi: 10.1038/bjc.1976.114.

Responses of cancer patients in the MEM test: not just a function of charge on basic proteins

Free PMC article
Comparative Study

Responses of cancer patients in the MEM test: not just a function of charge on basic proteins

A Shaw et al. Br J Cancer. 1976 Jul.
Free PMC article

Abstract

It has been reported that lymphocytes from cancer patients give positive responses to PPD, myelin basic protein, tumour basic protein, and certain histone fractions in the MEM test. The underlying mechanisms of the MEM test are poorly understood, but it is widely assumed that it detects immunological sensitization to specific antigenic determinants. The cross-reactivity experienced is interpreted as indicating shared antigenicity. Since all the stimulatory proteins are strongly basic we investigated an alternative explanation that responsiveness is a function of electrical charge by comparing the known stimulatory proteins in the MEM test with two others of similar basicity: lysozyme and cytochrome-C. We obtained highly significant stimulation with PPD, tryptophane peptide of myelin, and tumour basic protein using Mantoux + cancer patients, but found no response to other basic proteins. We failed to confirm the reported activity of histone F2a. Our results indicate that basicity alone is insufficient to elicit response, and strengthens the concept that the MEM test is measuring sensitization to the determinants shared by myelin and tumour basic protein.

PubMed Disclaimer

References

    1. Br J Cancer. 1975 Jul;32(1):28-33 - PubMed
    1. Clin Exp Immunol. 1975 Oct;22(1):16-21 - PubMed
    1. Lancet. 1970 Dec 26;2(7687):1337-41 - PubMed
    1. Nature. 1971 Sep 24;233(5317):284-6 - PubMed
    1. Lancet. 1972 Sep 23;2(7778):627-9 - PubMed

Publication types